P58.41
Neonatal jaundice due to drugs or toxins transmitted from mother
Clinical Classification Guidelines
Medical Intelligence & Overview
Neonatal jaundice is a common condition that occurs in newborns, characterized by a yellowish coloration of the skin and the whites of the eyes. Specifically, the code P58.41 refers to jaundice in newborns caused by drugs or toxins transmitted from the mother during pregnancy or breastfeeding. This type of jaundice results from substances passing from the mother to the baby, leading to increased bilirubin levels in the infant's bloodstream. Recognizing this condition is essential for proper management and care of affected newborns.
Causes & Symptoms
Clinical Causes: Maternal use of certain medications during pregnancy or breastfeeding, such as antibiotics, anti-epileptics, or other hepatotoxic drugs. Transfer of toxins from the mother to the fetus through the placenta or breast milk. Metabolic or genetic conditions that affect the processing of drugs or toxins in the infant's body, resulting in increased bilirubin levels.
Key Symptoms: Yellowing of the skin and sclerae (the whites of the eyes) in the newborn. Lethargy or unusual sleepiness. Poor feeding or difficulty feeding. Vomiting or irritability. Dark-colored urine and pale stools in severe cases. In extreme cases, signs of neurological damage such as seizures, indicating kernicterus.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of neonatal jaundice due to maternal drugs or toxins involves a combination of medical history, clinical examination, and laboratory testing. Key aspects include: - Reviewing the mother's medication and toxin exposure history. - Fetal and neonatal bilirubin levels measured through blood tests. - Monitoring the severity and progression of jaundice visually and biologically. - Additional tests may include liver function tests, blood counts, and assessments for hemolytic disease or other metabolic disorders. - In some cases, testing the levels of specific drugs or toxins in the infant's blood helps determine causality.
Treatment Protocols: Management of this condition focuses on reducing bilirubin levels and addressing the source of toxin exposure. Treatment options include: - Phototherapy to facilitate the breakdown of bilirubin in the skin. - Exchange transfusion in severe cases to rapidly decrease bilirubin levels. - Discontinuing or adjusting maternal medications that may be contributing to the jaundice. - Ensuring proper feeding to promote bilirubin elimination through urine and stool. - Close monitoring of bilirubin levels and neurological status. - Supportive care for symptoms and complications as needed. It is essential to collaborate with healthcare providers to determine the best approach for each individual case, especially considering maternal medication adjustments and neonatal support.
Clinical Advice & FAQs
Billing Guidance
Is P58.41 a billable ICD-10 code?
Yes, P58.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P58.41?
Clinical documentation must specify the nature of Neonatal jaundice due to drugs or toxins transmitted from mother and any associated comorbidities for accurate reporting.
Cite this Clinical Reference